Systems and methods for reagentless test strips
A system for detecting an analyte with a reagentless dry test strip includes a collector for collecting a blood sample from a user. The system additionally includes a mixer for receiving the collector and mixing the blood sample. The system additionally includes reagents, located in the mixer, for mixing with the blood sample. The system additionally includes a dry test strip for receiving the blood sample mixed with the reagents.
1. A system for detecting an analyte with a reagentless dry test strip, comprising:
a dry test strip including a reagentless membrane which does not include any reagents;
a collector for collecting a blood sample from a user;
a mixer separate from and shaped to mate with the collector, the mixer having a first condition separate from the collector and a second condition mated with the collector; and
one or more reagents in the liquid form located in the mixer for forming a mixture with the blood sample when the mixer is mated with the collector, the one or more reagents effective to cause a color change of the mixture while within the mixer prior to dosing the mixture to the dry test strip,
the reagentless membrane of the dry test strip being configured for receiving the mixture from the mixer.
2. The system of claim 1 , wherein the collector includes a capillary tube.
3. The system of claim 1 , wherein the mixer is shaped to seal with the collector when the collector is inserted into the mixer.
4. The system of claim 1 , wherein the dry test strip includes a spreading layer.
5. The system of claim 1 , wherein the dry test strip includes a first red blood cell separation layer.
6. The system, of claim 5 , wherein the dry test strip includes a second red blood cell separation layer.
7. The system of claim 1 , wherein the one or more reagents provide for the testing of total cholesterol.
8. The system of claim 7 , wherein the one or more reagents include cholesterol esterase, cholesterol oxidase, horseradish peroxidase, and quinoneimine chromophore precursors selected from the list consisting of: 4-amino antipyrine (4-AAP) and N-Ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-dimethylaniline, sodium salt and monohydrate (MAOS).
9. The system of claim 1 and further comprising:
a casing receiving the dry test strip and defining an application window; and
a first red blood cell separation layer received in the casing and positioned closer to the application window than the reagentless membrane.
10. The system of claim 1 and further comprising: a casing receiving the dry test strip and defining a reading window, the reagentless membrane being positioned adjacent to the reading window; and a first red blood cell separation layer is received in the casing and positioned closer to the reading window than the reagentless membrane.